RDS - CPAP or surfactant or both

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue SUPPL. 464, 2012, Pages 24-28

  Bohlin, Kajsa ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Continuous positive airway pressure; newborn; pulmonary surfactant; respiratory distress syndrome

Indexed keywords

SURFACTANT;

ARTIFICIAL VENTILATION; DELIVERY ROOM; EVIDENCE BASED PRACTICE; HUMAN; INFANT DISEASE; INTUBATION; NONINVASIVE VENTILATION; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY DISTRESS SYNDROME; REVIEW;

COMBINED MODALITY THERAPY; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERMITTENT POSITIVE-PRESSURE VENTILATION; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 84858390183     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2011.02543.x     Document Type: Review

References (39)

1. Avery ME, Mead J,. Surface properties in relation to atelectasis and hyaline membrane disease. AMA J Dis Child 1959; 97 (Pt 1): 517-23.
2. Dreyfuss D, Saumon G,. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998; 157: 294-323. (Pubitemid 28071297)
3. Soll RF, Hoekstra RE, Fangman JJ, Corbet AJ, Adams JM, James LS, et al., Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross collaborative surfactant prevention study Group. Pediatrics 1990; 85: 1092-102. (Pubitemid 20184734)
4. Lee K, Khoshnood B, Wall SN, Chang Y, Hsieh HL, Singh JK,. Trend in mortality from respiratory distress syndrome in the United States, 1970-1995. J Pediatr 1999; 134: 434-40. (Pubitemid 30180624)
5. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, et al., Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The neonatology committee for the developmental network Pediatrics 2000; 105: 1194-201. (Pubitemid 30346886)
6. Sandri F, Ancora G, Lanzoni A, Tagliabue P, Colnaghi M, Ventura ML, et al., Prophylactic nasal continuous positive airways pressure in newborns of 28-31 weeks gestation: multicentre randomised controlled clinical trial. Arch Dis Child Fetal Neonatal Ed 2004; 89: F394-8. (Pubitemid 39178814)
7. Kamper J, Wulff K, Larsen C, Lindequist S,. Early treatment with nasal continuous positive airway pressure in very low-birth-weight infants. Acta Paediatr 1993; 82: 193-7. (Pubitemid 23101492)
8. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al., European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants-2010 update. Neonatology 2010; 97: 402-17.
9. Soll RF, Morley CJ,. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001; 2: CD000510.
10. Yost CC, Soll RF,. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000; 2: CD001456.
11. Fellman V, Hellstrom-Westas L, Norman M, Westgren M, Kallen K, Lagercrantz H, et al., One-year survival of extremely preterm infants after active perinatal care in Sweden. JAMA 2009; 301: 2225-33.
12. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB,. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700-8. (Pubitemid 351240749)
13. Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, et al., Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010; 362: 1970-9.
14. Fuchs H, Lindner W, Leiprecht A, Mendler MR, Hummler HD,. Predictors of early nasal CPAP failure and effects of various intubation criteria on the rate of mechanical ventilation in preterm infants of <29 weeks gestational age. Arch Dis Child Fetal Neonatal Ed 2011; Sep; 96 (5): F343-7.
15. Locke R, Greenspan JS, Shaffer TH, Rubenstein SD, Wolfson MR,. Effect of nasal CPAP on thoracoabdominal motion in neonates with respiratory insufficiency. Pediatr Pulmonol 1991; 11: 259-64.
16. Mulrooney N, Champion Z, Moss TJ, Nitsos I, Ikegami M, Jobe AH,. Surfactant and physiologic responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med 2005; 171: 488-93. (Pubitemid 40444249)
17. Jobe AH, Kramer BW, Moss TJ, Newnham JP, Ikegami M,. Decreased indicators of lung injury with continuous positive expiratory pressure in preterm lambs. Pediatr Res 2002; 52: 387-92. (Pubitemid 34920270)
18. + channel expression is one of the pathogenic mechanisms leading to human neonatal respiratory distress syndrome. Proc Assoc Am Physicians 1996; 108: 345-55.
19. Saunders RA, Milner AD, Hopkin IE,. The effects of continuous positive airway pressure on lung mechanics and lung volumes in the neonate. Biol Neonate 1976; 29: 178-86.
20. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, et al., Is chronic lung disease in low birth weight infants preventable? A survey of eight centers Pediatrics 1987; 79: 26-30. (Pubitemid 17060953)
21. Vanpee M, Walfridsson-Schultz U, Katz-Salamon M, Zupancic JA, Pursley D, Jonsson B,. Resuscitation and ventilation strategies for extremely preterm infants: a comparison study between two neonatal centers in Boston and Stockholm. Acta Paediatr 2007; 96: 10-6; discussion 8-9.
22. Te Pas AB, Spaans VM, Rijken M, Morley CJ, Walther FJ,. Early nasal continuous positive airway pressure and low threshold for intubation in very preterm infants. Acta Paediatr 2008; 97: 1049-54.
23. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, et al., Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010; 125: e1402-9.
24. Rojas MA, Lozano JM, Rojas MX, Laughon M, Bose CL, Rondon MA, et al., Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Pediatrics 2009; 123: 137-42.
25. Dunn MS, Kaempf J, de Klerk A, de Klerk R, Reilly M, Howard D, Ferrelli K, O'Connor J, Soll RF, Vermont Oxford Network DRM Study Group. Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates. Pediatrics 2011; 128 (5): e1069-76.
26. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, et al., Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994; 331: 1051-5. (Pubitemid 24317697)
27. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, et al., Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999; 103: E24.
28. Bohlin K, Gudmundsdottir T, Katz-Salamon M, Jonsson B, Blennow M,. Implementation of surfactant treatment during continuous positive airway pressure. J Perinatol 2007; 27: 422-7. (Pubitemid 47033755)
29. Dani C, Bertini G, Pezzati M, Cecchi A, Caviglioli C, Rubaltelli FF,. Early extubation and nasal continuous positive airway pressure after surfactant treatment for respiratory distress syndrome among preterm infants <30 weeks' gestation. Pediatrics 2004; 113: e560-3.
30. Reininger A, Khalak R, Kendig JW, Ryan RM, Stevens TP, Reubens L, et al., Surfactant administration by transient intubation in infants 29 to 35 weeks' gestation with respiratory distress syndrome decreases the likelihood of later mechanical ventilation: a randomized controlled trial. J Perinatol 2005; 25: 703-8. (Pubitemid 41655644)
31. Victorin LH, Deverajan LV, Curstedt T, Robertson B,. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease - a pilot study. Biol Neonate 1990; 58: 121-6. (Pubitemid 20279318)
32. Stevens TP, Harrington EW, Blennow M, Soll RF,. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007; 4: CD003063.
33. Kribs A, Vierzig A, Hunseler C, Eifinger F, Welzing L, Stutzer H, et al., Early surfactant in spontaneously breathing with nCPAP in ELBW infants - a single centre four year experience. Acta Paediatr 2008; 97: 293-8. (Pubitemid 351514153)
34. Dargaville PA, Aiyappan A, Cornelius A, Williams C, De Paoli AG,. Preliminary evaluation of a new technique of minimally invasive surfactant therapy. Arch Dis Child Fetal Neonatal Ed 2010; 96 (4): F243-8.
35. Welzing L, Kribs A, Huenseler C, Eifinger F, Mehler K, Roth B,. Remifentanil for INSURE in preterm infants: a pilot study for evaluation of efficacy and safety aspects. Acta Paediatr 2009; 98: 1416-20.
36. Dani C, Berti E, Barp J,. Risk factors for INSURE failure in preterm infants. Minerva Pediatr 2010; 62 (3 Suppl 1): 19-20.
37. Wolfgang Göpel, Angela Kribs, Andreas Ziegler, Reinhard Laux, Thomas Hoehn, Christian Wieg, Jens Siegel, Stefan Avenarius, Axel von der Wense, Matthias Vochem, Peter Groneck, Ursula Weller, Jens Möller, Christoph Härtel, Sebastian Haller, Bernhard Roth, Egbert Herting, on behalf of the German Neonatal Network. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 2011; 378: 1627-34.
38. Daniel IW, Fiori HH, Piva JP, Munhoz TP, Nectoux AV, Fiori RM,. Lamellar body count and stable microbubble test on gastric aspirates from preterm infants for the diagnosis of respiratory distress syndrome. Neonatology 2010; 98: 150-5.
39. Verder H, Ebbesen F, Brandt J, Dahl M, Esberg G, Eschen C, et al., Lamellar body counts on gastric aspirates for prediction of respiratory distress syndrome. Acta Paediatr 2011; 100: 175-80.